Transgenic Overexpression of Galectin-3 in Pancreatic β Cells Attenuates Hyperglycemia in Mice: Synergistic Antidiabetic Effect With Exogenous IL-33.

Резултати

Naziv:	Transgenic Overexpression of Galectin-3 in Pancreatic β Cells Attenuates Hyperglycemia in Mice: Synergistic Antidiabetic Effect With Exogenous IL-33.
Autori :	Srejović, Ivan
Godina:	2021
Publikacija:	Frontiers in Pharmacology
ISSN:	1663-9812 Frontiers in Pharmacology Pretraži identifikator
Izdavač:	Lausanne: Frontiers Media S.A.
Tip rezultata:	Naučni članak
Kolacija:	vol. 12 str. 714683
DOI:	10.3389/fphar.2021.714683
WoS-ID:	000722354200001
Scopus-ID:	2-s2.0-85119409943
PMID:	34803672
URI:	https://www.frontiersin.org/articles/10.3389/fphar.2021.714683/full http://radar.ibiss.bg.ac.rs/handle/123456789/4697 https://enauka.gov.rs/handle/123456789/336969 https://scidar.kg.ac.rs/handle/123456789/13986
URL:	https://www.frontiersin.org/articles/10.3389/fphar.2021.714683/full
Projekat:	Uticaj IL-33/ST2 signalnog puta i galektina-3 u patogenezi eksperimentalnih periapikalnih promena (RS-175071) Swiss National Science Foundation Faculty of Medical Sciences, University of Kragujevac, Serbia (JP13-17)
M-kategorija:	21aM21a - Vodeći međunarodni časopis kategorije M21a

7
SCOPUS^TM

4
PubMed Central^TM

1
OpenCitations

7
WEB OF SCIENCE^TM

Алт метрика

Dimensions

Unpaywall

Creative Commons лиценца